132
Views
17
CrossRef citations to date
0
Altmetric
Original Research

Comparison of effects of alcaftadine and olopatadine on conjunctival epithelium and eosinophil recruitment in a murine model of allergic conjunctivitis

&
Pages 77-84 | Published online: 08 Feb 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (11)

Hiroshi Fujishima, Tomoko Hasunuma, Tetsuya Kawakita, Takuro Sekiya, Paul Gomes & David A. Hollander. (2021) Efficacy of Alcaftadine 0.25% (AGN-229666) for Once-daily Prevention of Cedar-Pollen Allergic Conjunctivitis: A Phase 3 Randomized Study. Ocular Immunology and Inflammation 29:7-8, pages 1621-1626.
Read now
Hiroshi Nakatani, Paul Gomes, Ron Bradford, Qiang Guo, Eleonora Safyan & David A. Hollander. (2019) Alcaftadine 0.25% versus Olopatadine 0.1% in Preventing Cedar Pollen Allergic Conjunctivitis in Japan: A Randomized Study. Ocular Immunology and Inflammation 27:4, pages 622-631.
Read now
Alexei Gonzalez-Estrada, Keerthi Reddy, Ves Dimov & Frank Eidelman. (2017) Olopatadine hydrochloride ophthalmic solution for the treatment of allergic conjunctivitis. Expert Opinion on Pharmacotherapy 18:11, pages 1137-1143.
Read now
DeGaulle I Chigbu & Alissa M Coyne. (2015) Update and clinical utility of alcaftadine ophthalmic solution 0.25% in the treatment of allergic conjunctivitis. Clinical Ophthalmology 9, pages 1215-1225.
Read now
Paul Gomes, Connie Slocum, Lisa M Smith & Mark B Abelson. (2015) Challenges faced in clinical trials for chronic allergic conjunctivitis. Expert Review of Ophthalmology 10:5, pages 509-518.
Read now
Mark B Abelson, Sirikishan Shetty, Michael Korchak, Salim I Butrus & Lisa M Smith. (2015) Advances in pharmacotherapy for allergic conjunctivitis. Expert Opinion on Pharmacotherapy 16:8, pages 1219-1231.
Read now
Paramdeep S Bilkhu, Shehzad A Naroo & James S Wolffsohn. (2015) Treatment of ocular allergies: nonpharmacologic, pharmacologic and immunotherapy. Expert Review of Ophthalmology 10:3, pages 257-266.
Read now
Monica Baiula & Santi Spampinato. (2014) Phase II drugs under investigation for allergic conjunctivitis. Expert Opinion on Investigational Drugs 23:12, pages 1671-1686.
Read now
Paulo J Gomes, George W Ousler, Donna L Welch, Lisa M Smith, Jeffrey Coderre & Mark B Abelson. (2013) Exacerbation of signs and symptoms of allergic conjunctivitis by a controlled adverse environment challenge in subjects with a history of dry eye and ocular allergy. Clinical Ophthalmology 7, pages 157-165.
Read now
Stacey Ackerman, Francis D’Ambrosio$suffix/text()$suffix/text(), Jack V Greiner, Linda Villanueva, Joseph B Ciolino & David A Hollander. (2013) A multicenter evaluation of the efficacy and duration of action of alcaftadine 0.25% and olopatadine 0.2% in the conjunctival allergen challenge model. Journal of Asthma and Allergy 6, pages 43-52.
Read now
Annabelle C Gallois-Bernos & Robin L Thurmond. (2012) Alcaftadine, a new antihistamine with combined antagonist activity at histamine H1, H2, and H4 receptors. Journal of Receptor, Ligand and Channel Research 5, pages 9-20.
Read now

Articles from other publishers (6)

Akila KDr.Dr., Sriya SridharDr.Dr., Swetha SridharDr.Dr. & C.R. JayanthiDr.Dr.. (2022) “A COMPARATIVE STUDY OF EFFICACY AND SAFETY OF ALCAFTADINE 0.25% VERSUS OLOPATADINE HYDROCHLORIDE 0.2% IN ALLERGIC CONJUNCTIVITIS AT A TERTIARY CARE HOSPITAL”. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH, pages 34-37.
Crossref
Anand M. Lahoti, Narendra B. Ambhaikar, D.M. Rajagopal Reddy, Arnab Roy, Kallam V.S.R. Krishna Reddy & S. Mahender Rao. (2022) Investigation of Alcaftadine using a Double Oxidation Process by Eliminating Column Chromatography. Asian Journal of Chemistry 34:6, pages 1431-1438.
Crossref
Snigdha Sen, Himanshu Kumar Yadav & Prerana Singh. (2020) A Comparative Study of Efficacy of Alcaftadine 0.25 % and Olopatadine 0.2 % in Allergic Conjunctivitis. Journal of Evidence Based Medicine and Healthcare 7:52, pages 3153-3158.
Crossref
Pushpendra ChotiyaDrDrArvind ChauhanDrDr. (2020) AN EFFICACY COMPARISON STUDY BETWEEN TOPICAL ANTI ALLERGIC DRUGS IN PATIENTS WITH ALLERGIC CONJUNCTIVITIS IN WESTERN RAJASTHAN. PARIPEX INDIAN JOURNAL OF RESEARCH, pages 22-24.
Crossref
DeGaulle I. Chigbu & Bhawanjot K. Minhas. (2018) Immunopathology of Allergic Conjunctivitis. European Medical Journal, pages 76-83.
Crossref
Mark B. Abelson, James T. McLaughlin & Paul J. Gomes. (2011) Antihistamines in Ocular Allergy: Are They All Created Equal?. Current Allergy and Asthma Reports 11:3, pages 205-211.
Crossref